Low Molecular Weight Nucleoside Gelators: A Platform for Protein Aggregation Inhibition.
gel
nucleoside gelator
protein aggregation inhibition
Journal
Molecular pharmaceutics
ISSN: 1543-8392
Titre abrégé: Mol Pharm
Pays: United States
ID NLM: 101197791
Informations de publication
Date de publication:
07 01 2019
07 01 2019
Historique:
pubmed:
30
11
2018
medline:
19
11
2019
entrez:
30
11
2018
Statut:
ppublish
Résumé
Low molecular weight nucleoside gelators hold great promise in drug delivery and particularly for the delivery of biologics because of their excellent biocompatibility. However, the influence of these gelators on protein aggregation inhibition has not yet been studied. Protein aggregation is the most significant cause of protein instability and can severely impact the biological activity of the protein, impairing the quality and safety of the formulation. Herein, we report the ability of a nucleoside-based gelator, N4-octanoyl-2'-deoxycytidine, to inhibit protein aggregation. Using turbidimetric, spectroscopic, and microscopic methods, we demonstrate that protein aggregation inhibition is dependent on gelator concentration. Moreover, we have found that the protein is still functionally active in the hydrogel.
Identifiants
pubmed: 30495960
doi: 10.1021/acs.molpharmaceut.8b01013
doi:
Substances chimiques
Nucleosides
0
Protein Aggregates
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
462-467Subventions
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/L013827/1
Pays : United Kingdom